UBS Group Cuts Canada Goose (NYSE:GOOS) Price Target to $13.00

Canada Goose (NYSE:GOOSFree Report) had its price objective trimmed by UBS Group from $14.00 to $13.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has a neutral rating on the stock.

Several other analysts also recently commented on GOOS. Evercore raised their price objective on shares of Canada Goose from $12.00 to $13.00 and gave the stock an in-line rating in a research report on Friday, May 17th. Evercore ISI lifted their price target on shares of Canada Goose from $12.00 to $13.00 and gave the company an in-line rating in a research note on Friday, May 17th. Raymond James lowered shares of Canada Goose from an outperform rating to a market perform rating in a report on Tuesday, July 23rd. The Goldman Sachs Group raised their target price on Canada Goose from $11.00 to $12.50 and gave the company a neutral rating in a research note on Friday, May 17th. Finally, Barclays dropped their price target on Canada Goose from $13.00 to $12.00 and set an equal weight rating on the stock in a research note on Friday. Eight analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of Hold and an average target price of $14.07.

View Our Latest Report on GOOS

Canada Goose Trading Down 2.9 %

Canada Goose stock traded down $0.31 during mid-day trading on Friday, hitting $10.43. 244,080 shares of the stock were exchanged, compared to its average volume of 997,624. The firm’s fifty day simple moving average is $12.84 and its two-hundred day simple moving average is $12.44. The company has a quick ratio of 0.95, a current ratio of 2.39 and a debt-to-equity ratio of 0.92. Canada Goose has a 12 month low of $9.80 and a 12 month high of $17.30. The stock has a market capitalization of $1.01 billion, a price-to-earnings ratio of 29.03, a PEG ratio of 0.66 and a beta of 1.35.

Canada Goose (NYSE:GOOSGet Free Report) last announced its quarterly earnings data on Thursday, May 16th. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.07. Canada Goose had a return on equity of 24.94% and a net margin of 4.66%. The company had revenue of $265.56 million for the quarter, compared to the consensus estimate of $232.36 million. Analysts forecast that Canada Goose will post 0.81 EPS for the current year.

Hedge Funds Weigh In On Canada Goose

A number of hedge funds have recently added to or reduced their stakes in the stock. SG Americas Securities LLC purchased a new stake in shares of Canada Goose in the fourth quarter worth approximately $124,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Canada Goose by 17.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,725 shares of the company’s stock valued at $177,000 after buying an additional 2,002 shares during the last quarter. Total Clarity Wealth Management Inc. bought a new stake in Canada Goose during the fourth quarter worth $198,000. Claro Advisors LLC purchased a new stake in Canada Goose in the 1st quarter valued at $210,000. Finally, Shaker Investments LLC OH bought a new position in Canada Goose during the 4th quarter valued at $236,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Canada Goose

(Get Free Report)

Canada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.

Featured Articles

Analyst Recommendations for Canada Goose (NYSE:GOOS)

Receive News & Ratings for Canada Goose Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canada Goose and related companies with MarketBeat.com's FREE daily email newsletter.